Cargando…
Quantification of transgene expression in GSH AAVS1 with a novel CRISPR/Cas9-based approach reveals high transcriptional variation
Genomic safe harbors (GSH) are defined as sites in the host genome that allow stable expression of inserted transgenes while having no adverse effects on the host cell, making them ideal for use in basic research and therapeutic applications. Silencing and fluctuations in transgene expression would...
Autores principales: | Inderbitzin, Anne, Loosli, Tom, Kouyos, Roger D., Metzner, Karin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234542/ https://www.ncbi.nlm.nih.gov/pubmed/35795775 http://dx.doi.org/10.1016/j.omtm.2022.06.003 |
Ejemplares similares
-
Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9
por: Li, Hao, et al.
Publicado: (2018) -
Transcriptome profiles of latently- and reactivated HIV-1 infected primary CD4(+) T cells: A pooled data-analysis
por: Inderbitzin, Anne, et al.
Publicado: (2022) -
Variable expression and silencing of CRISPR-Cas9 targeted transgenes identifies the
AAVS1 locus as not an entirely safe harbour
por: Bhagwan, Jamie R., et al.
Publicado: (2020) -
CRISPR/Cas9 as an antiviral against Orthopoxviruses using an AAV vector
por: Siegrist, Cathryn M., et al.
Publicado: (2020) -
AAV-Mediated CRISPR/Cas9 Gene Editing in Murine Phenylketonuria
por: Richards, Daelyn Y., et al.
Publicado: (2019)